Xencor Share Price

Xencor Share Price

NASDAQ: XNCR | Mid Cap | Healthcare
$33.25
-$0.76 (-2.23%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Xencor Stock Performance

Open
$34.01
Prev. Close
$34.01
Circuit Range
N/A
Day Range
$33.26 - $34.14
Year Range
$10.38 - $40.57
Volume
50,065
Average Traded
$33.59

Xencor Share Price Today

As of 22 November 2026, Xencor, Inc.'s share price is $33.25. The stock opened at $34.01, compared to its previous close of $34.01. During today's trading session, Xencor, Inc.'s share price traded between $33.26 and $34.14, with an average price of $33.70. Over the past 52 weeks, the stock has recorded a high of $40.57 and a low of $10.38. In terms of performance, Xencor, Inc.'s share price has risen by 180.12% over the last six months and is up 92.20% on a year-on-year basis.

Xencor Share Price Chart

Line chart of the Xencor price trend over the selected period. The price fell overall, ranging from 33.18 to 34.24, ending at 33.25.
$33.26$34.14
L
Show Current Price
H

Xencor Stock Fundamentals & Key Indicators

Market Cap
$2.47B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.57
Revenue (TTM)
$125.58B
Return On Equity (TTM)
-21.03%
Profit Margin
-73.20%
Debt to Equity
0.17
Quarterly Earnings Growth YoY
693.08%

Xencor Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$28.24$4.52$51.22$116.52
Net Profit-$6.65-$128.92-$21.73$39.44
Net Profit Margin-23.55%-2852.21%-42.42%33.85%
Income ChangeN/A-1838.65%83.14%281.50%

Xencor Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$164.58$174.62$110.49$125.58
Net Profit-$55.18-$133.13-$232.62-$91.92
Net Profit Margin-33.53%-76.24%-210.53%-73.20%
Income ChangeN/A-141.26%-74.73%60.48%

Xencor Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets275.67374.34329.53170.92
Current Assets599.82577.6635.6675.34
Total Assets875.5951.95965.14846.27
Non Current Liabilities144.0190.49229.1354.93
Current Liabilities95.9187.4373.9263.84
Total Liabilities239.91277.92303.05118.77
Shareholders' Equity635.59674.03662.09727.5

Xencor Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-135.12-202.19-77.9324.49
Investing139.99-7.87-111.07-119.73
Financing8.23197.15189.225.7

About Xencor

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Xencor Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$29.99
$33.38
+11.94%
Oct 2026
$24.75
$29.82
+19.28%
Sep 2026
$27.17
$25.00
-13.22%
Aug 2026
$20.24
$28.81
+42.34%
Jul 2026
$15.97
$20.24
+25.56%
Jun 2026
$11.79
$16.12
+35.80%
May 2026
$11.84
$11.87
-0.46%
Apr 2026
$12.31
$11.93
-0.87%
Mar 2026
$12.45
$12.03
-5.94%
Feb 2026
$12.22
$12.79
+5.88%
Jan 2026
$15.24
$12.08
-21.05%
Dec 2025
$17.00
$15.30
-11.56%

Xencor Share Price FAQs